Type 2 Continuous Glucose Monitoring Academy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-21
SponsorChildren's Hospital Los Angeles

About this trial

The goal of this clinical trial is to evaluate the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes (T2D):

* The first aim is to determine how feasible it is to adapt the Continuous Glucose Monitoring Academy curriculum to teach youth with T2D glucose management strategies. * The second aim is to evaluate the effects of the Continuous Glucose Monitoring Academy metrics. * The third aim is to explore the relationships between these metrics with diabetes distress, diabetes family responsibilities, and process metrics.

Participants will join for a total of four weeks of education, followed by a six-month clinical review. They will have access to an online workbook and videos, and will participate in virtual sessions with a diabetes educator who will cover glucose management strategies in-depth. Participants will wear their preferred Continuous Glucose Monitoring system (Dexcom or FreeStyle Libre) provided via insurance and inserted at the baseline visit.

Eligibility criteria

Qualifiers

Current age of 8-21 years;

T2D diagnosis;

Able to speak, read, and write English or Spanish

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Continuous Glucose Monitoring Academy
  • Standard Education

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Children's Hospital Los Angeles

Lead sponsor

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator